Kura Oncology Statistics Share Statistics Kura Oncology has 86.8M
shares outstanding. The number of shares has increased by 11.62%
in one year.
Shares Outstanding 86.8M Shares Change (YoY) 11.62% Shares Change (QoQ) 0.26% Owned by Institutions (%) 93.81% Shares Floating 84.12M Failed to Deliver (FTD) Shares 53,538 FTD / Avg. Volume 3.2%
Short Selling Information The latest short interest is 10.85M, so 12.5% of the outstanding
shares have been sold short.
Short Interest 10.85M Short % of Shares Out 12.5% Short % of Float 12.53% Short Ratio (days to cover) 6.15
Valuation Ratios The PE ratio is -4.31 and the forward
PE ratio is -3.92.
Kura Oncology's PEG ratio is
1.5.
PE Ratio -4.31 Forward PE -3.92 PS Ratio 13.93 Forward PS 4.1 PB Ratio 1.81 P/FCF Ratio 5.61 PEG Ratio 1.5
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Kura Oncology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 9.46,
with a Debt / Equity ratio of 0.04.
Current Ratio 9.46 Quick Ratio 9.46 Debt / Equity 0.04 Debt / EBITDA -0.1 Debt / FCF 0.12 Interest Coverage -119.33
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $280.64K Profits Per Employee $-906.16K Employee Count 192 Asset Turnover 0.07 Inventory Turnover n/a
Taxes Income Tax 2.02M Effective Tax Rate -1.17%
Stock Price Statistics The stock price has increased by -46.95% in the
last 52 weeks. The beta is 0.32, so Kura Oncology's
price volatility has been higher than the market average.
Beta 0.32 52-Week Price Change -46.95% 50-Day Moving Average 7.57 200-Day Moving Average 7.15 Relative Strength Index (RSI) 69.72 Average Volume (20 Days) 1,671,547
Income Statement In the last 12 months, Kura Oncology had revenue of 53.88M
and earned -173.98M
in profits. Earnings per share was -2.02.
Revenue 53.88M Gross Profit 53.03M Operating Income -193.19M Net Income -173.98M EBITDA -169.5M EBIT -170.35M Earnings Per Share (EPS) -2.02
Full Income Statement Balance Sheet The company has 224.46M in cash and 16.59M in
debt, giving a net cash position of 207.87M.
Cash & Cash Equivalents 224.46M Total Debt 16.59M Net Cash 207.87M Retained Earnings -895.42M Total Assets 682.42M Working Capital 552.9M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 134.32M
and capital expenditures -472K, giving a free cash flow of 133.84M.
Operating Cash Flow 134.32M Capital Expenditures -472K Free Cash Flow 133.84M FCF Per Share 1.55
Full Cash Flow Statement Margins Gross margin is 98.43%, with operating and profit margins of -358.55% and -322.89%.
Gross Margin 98.43% Operating Margin -358.55% Pretax Margin -319.15% Profit Margin -322.89% EBITDA Margin -314.57% EBIT Margin -358.55% FCF Margin 248.4%
